PROJECT 4 - DTI AND MTI STUDIES IN SCHIZOPHRENIA

项目 4 - 精神分裂症的 DTI 和 MTI 研究

基本信息

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Understanding of the neuropathology of schizophrenia has been advanced by numerous magnetic resonance imaging (MRI) studies over the past decade, which confirms the presence of structural brain abnormalities in schizophrenia, including volume alterations of the ventricles, frontal lobe, medial temporal lobe, superior temporal gyrus, inferior parietal lobe and subcortical brain regions (for review, see1). The distributed pattern and number of abnormalities observed in schizophrenia are consistent with a disturbance of connectivity within and between brain regions and a white matter abnormality underlying this disturbed neural connectivity. Indeed, prefrontal grey matter volume has been highly correlated with volume reductions in the amygdala-hippocampus complex and superior temporal gyrus in the brains of schizophrenic patients2. While numerous conventional MRI studies have reported grey matter abnormalities in schizophrenia1, relatively few in comparison have specifically assessed and reported modest but significant white matter volume decreases in schizophrenic brains3-9. Newer techniques such as diffusion tensor imaging (DTI), which allows inferences of the coherence of white matter tracts (anisotropy), and magnetization transfer imaging (MTI), which provides a putative measure of myelin in the brain (magnetization transfer ratio; MTR), extend our understanding of white matter deficits from merely assessing volumetric loss to providing preliminary imaging evidence for decreased organization in white matter tracts and subtle reductions in the myelin content of schizophrenic brains. These findings are also consistent with microscopic studies revealing ultrastructural alterations of myelinated fibers from the prefrontal cortex of schizophrenic patients10-12. In addition, demyelinating diseases such as adolescent onset metachromatic leukodystrophy and multiple sclerosis are associated with behavioral and cognitive disturbances similar to that observed in schizophrenia. The purpose of this study is to learn more about different brain areas in people who have been diagnosed with schizophrenia.
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者所在的机构。 在过去的十年中,通过大量的磁共振成像(MRI)研究,对精神分裂症的神经病理学的认识得到了提高,这些研究证实了精神分裂症存在脑结构异常,包括脑室、额叶、内侧颞叶、上级颞回、顶叶下叶和皮质下脑区的体积改变(综述见1)。 在精神分裂症中观察到的异常的分布模式和数量与脑区域内和脑区域之间的连接紊乱以及这种紊乱的神经连接的基础白色异常一致。 事实上,在精神分裂症患者的大脑中,前额叶灰质体积与杏仁核-海马复合体和上级颞回的体积减少高度相关2。 虽然许多传统的MRI研究都报告了精神分裂症患者的灰质异常1,但相比之下,相对较少的研究专门评估并报告了精神分裂症患者大脑中适度但显着的白色体积减少3 -9。 较新的技术,如扩散张量成像(DTI),可以推断白色物质束的相干性(各向异性)和磁化传递成像(MTI),其提供了脑中髓鞘的推定测量(磁化传递比;港铁),将我们对白色物质缺陷的理解从仅仅评估体积损失扩展到为白色物质束的组织减少提供初步成像证据,精神分裂症患者大脑中髓鞘含量的细微减少。这些发现也与揭示精神分裂症患者前额叶皮层有髓纤维超微结构改变的显微镜研究一致10 -12。此外,脱髓鞘疾病,如青少年发病的异染性脑白质营养不良和多发性硬化症与行为和认知障碍有关,类似于精神分裂症中观察到的。 这项研究的目的是更多地了解被诊断患有精神分裂症的人的不同大脑区域。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KENNETH L DAVIS其他文献

KENNETH L DAVIS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KENNETH L DAVIS', 18)}}的其他基金

PROJECT 4 - DTI AND MTI STUDIES IN SCHIZOPHRENIA
项目 4 - 精神分裂症的 DTI 和 MTI 研究
  • 批准号:
    7380528
  • 财政年份:
    2006
  • 资助金额:
    $ 3.34万
  • 项目类别:
PROJECT 4 - DIFFUSION TENSION IMAGING (DTI) AND MAGNETIZATION TRANSFER IMAGIN
项目 4 - 扩散张力成像 (DTI) 和磁化转移成像
  • 批准号:
    7202497
  • 财政年份:
    2005
  • 资助金额:
    $ 3.34万
  • 项目类别:
Project 4 - Diffusion Tension Imaging (DTI) and Magnetization Transfer Imagin...
项目 4 - 扩散张力成像 (DTI) 和磁化传递成像...
  • 批准号:
    7044882
  • 财政年份:
    2004
  • 资助金额:
    $ 3.34万
  • 项目类别:
FACILITY RENOVATION AND ANNENBERG CAGE WASH FACILITIY
设施改造和安纳伯格笼清洗设施
  • 批准号:
    6709023
  • 财政年份:
    2003
  • 资助金额:
    $ 3.34万
  • 项目类别:
White Matter Abnormalities in Schizophrenia
精神分裂症的白质异常
  • 批准号:
    6802037
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
White Matter Abnormalities in Schizophrenia
精神分裂症的白质异常
  • 批准号:
    6548216
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
White Matter Abnormalities in Schizophrenia
精神分裂症的白质异常
  • 批准号:
    6949622
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
ALPHA 2 AGONIST PLUS A CHOLINESTERASE INHIBITOR IN ALZHEIMERS DISEASE
ALPHA 2 激动剂加胆碱酯酶抑制剂治疗阿尔茨海默病
  • 批准号:
    6593368
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
White Matter Abnormalities in Schizophrenia
精神分裂症的白质异常
  • 批准号:
    6668631
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
White Matter Abnormalities in Schizophrenia
精神分裂症的白质异常
  • 批准号:
    7291187
  • 财政年份:
    2002
  • 资助金额:
    $ 3.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了